2026. 02. 20
20th Webinar : Scientific and Regulatory Limitations of Endogenous Biomarker Analysis
In March 2026, GCCL’s 20th webinar will be held under the theme of Scientific and Regulatory Limitations of Endogenous Biomarker Analysis. In clinical trials, endogenous biomarkers are widely used in various areas, including efficacy evaluation and PK/PD interpretation.However, questions still remain regarding their interpretation and appropriate scope of application. In this webinar, we will explore both the scientific background and regulatory perspectives of endogenous biomarker analysis, and share practical insights on how to interpret and appropriately utilize these data in clinical trials.👏Topic : Scientific and Regulatory Limitations of Endogenous Biomarker Analysis – Proper Interpretation and Scope of Use in Clinical TrialsDate : March 18, 2026 (Wed) 14:00 ~ 15:00Speaker : Kyungmin In, Unit Head, GCCLRegistration : https://us06web.zoom.us/webinar/register/WN_1D-C0ouJQyewSc0__NWLNg
Read more
> About GCCL > Newsroom > Webinar